Fluor to build US diabetes medicine plant
FLUOR has won a US$1.2bn engineering, procurement, construction and construction management contract from Novo Nordisk for a diabetes active pharmaceutical ingredient (API) manufacturing facility in North Carolina, US.
Recent Editions
Catch up on the latest news, views and jobs from The Chemical Engineer. Below are the four latest issues. View a wider selection of the archive from within the Magazine section of this site.
